MedPath

Study of the effectiveness of the 12-week weight loss program based on measurement of energy expenditure

Not Applicable
Conditions
obesity
Registration Number
JPRN-UMIN000022356
Lead Sponsor
agoya University
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete: follow-up continuing
Sex
All
Target Recruitment
40
Inclusion Criteria

Not provided

Exclusion Criteria

A person who has cancer, a serious underlying disease such as chronic inflammatory diseases currently. Diabetic patients in the insulin treatment. Who the doctor has determined that improper participation.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
weight loss at the end of the program (12 weeks after initial intervention).
Secondary Outcome Measures
NameTimeMethod
Changes of resting energy expenditure during weight loss. Change of body composition. Change of serum leptin level and hunger feeling. Presence or absence of BW rebound 3 month after the program.
© Copyright 2025. All Rights Reserved by MedPath